MOG and myeloid sarcoma: It has been possible to distinguish MOG antibody-associated NMOSD from MS with a specificity of 95% and a sensitivity of 91% by employing predefined MRI criteria for lesion distribution, including Dawson's fingers, subcortical U fiber lesions, and lesions adjacent to the lateral ventricles, as typical for MS (81).